Literature DB >> 21633288

Elevated triglycerides and risk of myocardial infarction in HIV-positive persons.

Signe W Worm1, David A Kamara, Peter Reiss, Ole Kirk, Wafaa El-Sadr, Christoph Fux, Eric Fontas, Andrew Phillips, Antonella D'Arminio Monforte, Stephane De Wit, Kathy Petoumenos, Nina Friis-Mller, Patrick Mercie, Jens D Lundgren, Caroline Sabin.   

Abstract

OBJECTIVES: To explore the relationship between elevated triglyceride levels and the risk of myocardial infarction (MI) in HIV-positive persons after adjustment for total cholesterol (TC), high-density lipoprotein-cholesterol (HDL-C) and nonlipid risk factors.
BACKGROUND: Although elevated triglyceride levels are commonly noted in HIV-positive individuals, it is unclear whether they represent an independent risk factor for MI.
METHODS: The incidence of MI during follow-up was stratified according to the latest triglyceride level. Multivariable Poisson regression models were used to describe the independent association between the latest triglyceride level and MI risk after adjusting for TC and HDL-C, nonlipids cardiovascular disease (CVD) risk factors, HIV and treatment-related factors.
RESULTS: The 33,308 persons included in the study from 1999 to 2008 experienced 580 MIs over 178,835 person-years. Unadjusted, the risk of MI increased by 67% [relative risk (RR) 1.67, 95% confidence interval 1.54-1.80] per doubling in triglyceride level. After adjustment for the latest TC and HDL-C level, the RR dropped to 1.33 (95% confidence interval 1.21-1.45); this effect was further attenuated by other CVD risk factors and the RR was reduced to 1.17 (95% confidence interval 1.06-1.29). In models that additionally adjusted for HIV and treatment factors, the risk was further diminished, although remained significant (RR 1.11, 95% confidence interval 1.01-1.23).
CONCLUSION: Higher triglyceride levels were marginally independently associated with an increased risk of MI in HIV-positive persons, although the extent of reduction in RR after taking account of latest TC, latest HDL-C and other confounders suggests that any independent effect is small.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21633288     DOI: 10.1097/QAD.0b013e32834917c6

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  15 in total

Review 1.  Risk of coronary heart disease in patients with HIV infection.

Authors:  Markella V Zanni; Judith Schouten; Steven K Grinspoon; Peter Reiss
Journal:  Nat Rev Cardiol       Date:  2014-10-21       Impact factor: 32.419

Review 2.  Update of the past year: a review from IDSA 2011.

Authors:  David L McCollum
Journal:  Top Antivir Med       Date:  2011-12

Review 3.  The burden of diabetes and hyperlipidemia in treated HIV infection and approaches for cardiometabolic care.

Authors:  Katherine Samaras
Journal:  Curr HIV/AIDS Rep       Date:  2012-09       Impact factor: 5.071

Review 4.  Body composition and metabolic changes in HIV-infected patients.

Authors:  Takara L Stanley; Steven K Grinspoon
Journal:  J Infect Dis       Date:  2012-06       Impact factor: 5.226

5.  Exogenous lipid uptake induces metabolic and functional reprogramming of tumor-associated myeloid-derived suppressor cells.

Authors:  Amir A Al-Khami; Liqin Zheng; Luis Del Valle; Fokhrul Hossain; Dorota Wyczechowska; Jovanny Zabaleta; Maria D Sanchez; Matthew J Dean; Paulo C Rodriguez; Augusto C Ochoa
Journal:  Oncoimmunology       Date:  2017-06-30       Impact factor: 8.110

Review 6.  The effects of dietary intervention on HIV dyslipidaemia: a systematic review and meta-analysis.

Authors:  Clare Stradling; Yen-Fu Chen; Tracy Russell; Martin Connock; G Neil Thomas; Shahrad Taheri
Journal:  PLoS One       Date:  2012-06-11       Impact factor: 3.240

7.  Differences in lipid measurements by antiretroviral regimen exposure in cohorts from Asia and australia.

Authors:  Amit C Achhra; Janaki Amin; Jennifer Hoy; Junko Tanuma; Thira Sirisanthana; David Nolan; Tuti Merati; Michelle Giles
Journal:  AIDS Res Treat       Date:  2012-05-14

8.  Lipid levels in HIV-positive men receiving anti-retroviral therapy are not associated with copy number variation of reverse cholesterol transport pathway genes.

Authors:  Rebecca B Marino; Lawrence A Kingsley; Shehnaz K Hussain; Jay H Bream; Sudhir Penogonda; Priya Duggal; Jeremy J Martinson
Journal:  BMC Res Notes       Date:  2015-11-21

9.  Cardiovascular risk assessment: a comparison of the Framingham, PROCAM, and DAD equations in HIV-infected persons.

Authors:  Max Weyler Nery; Celina Maria Turchi Martelli; Erika Aparecida Silveira; Clarissa Alencar de Sousa; Marianne de Oliveira Falco; Aline de Cássia Oliveira de Castro; Jorge Tannus Esper; Luis Carlos Silva e Souza; Marília Dalva Turchi
Journal:  ScientificWorldJournal       Date:  2013-10-21

10.  The effects of age on associations between markers of HIV progression and markers of metabolic function including albumin, haemoglobin and lipid concentrations.

Authors:  M Samuel; S Jose; A Winston; M Nelson; M Johnson; D Chadwick; M Fisher; C Leen; M Gompels; R Gilson; F A Post; P Hay; C A Sabin
Journal:  HIV Med       Date:  2013-11-19       Impact factor: 3.180

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.